Skip to content

Post-Traumatic Stress Disorder Focused Psychodynamic Psychotherapy

A Pilot Randomized Controlled Trial of Trauma-Focused Psychodynamic Psychotherapy (TFPP) at the VA in Veterans With PTSD

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03755401
Acronym
RCT of TFPP
Enrollment
75
Registered
2018-11-28
Start date
2018-11-02
Completion date
2027-05-31
Last updated
2025-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PTSD

Keywords

psychotherapy, psychodynamic psychotherapy

Brief summary

This is a randomized controlled trial of Trauma-Focused Psychodynamic Psychotherapy (TFPP) in comparison with TAU (at the VA) in a 2:1 ratio in 75 Veterans with PTSD who have not responded to standard treatment at the VA.

Detailed description

Veterans with PTSD are a highly vulnerable population with tremendous disability and unmet needs. Few VA patients with PTSD now actually receive evidence-based psychotherapy because current exposure-based treatments have low uptake. The project goal is to expand the range of PTSD psychotherapy treatments available at Veterans Administration Medical Centers. This pilot trauma recovery proposal takes the next step in translating a brief efficacious psychotherapy developed and tested for panic disorder, Panic Focused Psychodynamic Psychotherapy (PFPP) for Veterans with PTSD at the VA New York Harbor Healthcare System (VA NYHHCS). PFPP was developed, manualized, and studied in RCTs over the past two decades. We hope that Trauma-Focused Psychodynamic Psychotherapy (TFPP), an adaptation of PFPP, with its high response rates in panic disorder with/without agoraphobia, and non-exposure protocol, will fill crucial gaps in Veteran care. A major challenge facing psychotherapy research is translating and implementing efficacious therapies to the community. No psychodynamic psychotherapy for anxiety or PTSD has achieved this in the US. This pilot RCT represents a paradigm shift in its approach to trauma. TFPP will be the only PTSD treatment for Veterans to incorporate Veterans' input into refinement of the treatment as this project progresses. TFPP targets aspects of traumatic experience and approaches Veterans' lives more broadly than the symptom-focused treatments the VA currently offers our traumatized Veterans.

Interventions

OTHERTFPP

Trauma-Focused Psychodynamic Psychotherapy

OTHERTAU

treatment as usual at the VA for PTSD

Sponsors

VA New York Harbor Healthcare System
CollaboratorFED
Weill Medical College Clinical Science Translation Center
CollaboratorUNKNOWN
American Psychoanalytic Association (APsA)
CollaboratorUNKNOWN
International Psychoanalytic Association (IPA)
CollaboratorUNKNOWN
National Center for Advancing Translational Sciences (NCATS)
CollaboratorNIH
Montefiore Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

All assessments will be performed by blinded clinical assessors; randomization accomplished by computer algorhythm

Intervention model description

Randomized controlled trial of psychosocial interventions

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Reporting moderate PTSD, as defined by a CAPS score of \>40 * Have at least one of the following history with CPT and/or PE: * offered and declined * dropped out of treatment * been determined unsuitable by their treatment team * received treatment but continue to experience symptoms meeting entrance criteria. * Require stabilization on psychiatric medication for 2 month period prior to entry into study to avoid confounding treatments

Exclusion criteria

* Presence of SCID-5 assessed psychotic disorder, bipolar disorder, or substance use that would interfere with trial demands * Severe suicidality that would require immediate crisis management * Organic mental syndromes, delirium, or unstable medical conditions that would interfere with trial demands * Inability to meet trial demands.

Design outcomes

Primary

MeasureTime frameDescription
Change in PTSD symptoms as per DSM-5 as measured by CAPS-5baseline, 16 weeks (termination), 3 month follow-upClinician-Administered PTSD Scale for DSM-5 (CAPS-5). Low score indicates fewer PTSD symptoms, high score indicates more PTSD symptoms.

Secondary

MeasureTime frameDescription
Change in reflective capacity as measured by RF score.baseline, 16 weeks (termination), 3 month follow-upReflective Function Scale (RF). Low score indicates poor ability to reflect on relationships and self, high score, indicates better capacity to reflect on others and self.
Change in depression symptoms as measured by HDRS.baseline, 16 weeks (termination), 3 month follow-upHamilton Depression Rating Scale (HDRS). Low score indicates few depressive symptoms, high score indicates high level of depressive burden (depression)
Change in mental and physical symptoms as measured by VR-12.baseline, 16 weeks (termination), 3 month follow-upVeterans RAND 12-Item Health Survey (VR-12). The results of the VR-12 are summarized as two scores - a Mental Component Score (MCS) and a Physical Component Score (PCS). The scores may be reported as Z-scores (difference compared to the population average, measured in standard deviations). The United States population average PCS and MCS are both 50 points. The United States population standard deviation is 10 points. Therefore, each increment of 10 points above or below 50 corresponds to one standard deviation away from the population average.
Change in work and social adjustment as measured by WSAS.baseline, 16 weeks (termination), 3 month follow-upWork and Social Adjustment Scale (WSAS). Low score indicates good social and work adjustment, high score indicates impairment socially and at work.
Change in anxiety symptoms as measured by HARS.baseline, 16 weeks (termination), 3 month follow-upHamilton Anxiety Rating Scale (HARS). Low score indicates fewer state anxiety symptoms, high score indicates greater state anxiety symptoms
Childhood abuse history and trauma with CTQbaselineChildhood Trauma Questionnaire (CTQ). Several different domains: Emotional Abuse: None=5-8; Low=9-12; Moderate=13-15; Severe=16+ Physical Abuse: None=5-7; Low=8-9; Moderate=10-12; Severe=13+ Sexual Abuse: None=5; Low=6-7; Moderate=8-12; Severe=13+ Emotional Neglect: None=5-9; Low=10-14; Moderate=15-17; Severe=18+ Physical Neglect: None=5-7; Low=8-9; Moderate=10-12; Severe=13+
Change in adult separation anxiety symptoms as measured by the SCI-SASbaseline, 16 weeks (termination), 3 month follow-upSeparation anxiety-child and adult measure rating scale (SCI-SAS). Separate scores generated for childhood separation anxiety and adult separation anxiety. Low scores indicate few separation anxiety symptoms, high scores indicate large separation anxiety burden.
Assessment of life events on LEC.baselineLife Events Checklist (LEC). No composite score-tracks traumatic life events
Change in degree of limitation in ability to work as measured by WLQbaseline, 16 weeks (termination), 3 month follow-upWork Limitations Questionnaire (WLQ). Low score indicates few limitations at work, high score indicates many limitations at work

Countries

United States

Contacts

Primary ContactEmily Villeveuve
Emily.Villeneuve@va.gov(212) 686-7500
Backup ContactCory K Chen, Ph.D.
Cory.Chen@va.gov(212) 686-7500

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026